findmyKOL

Alexandra Wong, MD

Basic profile

Massachusetts General Hospital

ORCID↗NPI↗
✓ Full record
RegionBoston, MA · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Last active 2024findmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Alexandra Wong is a Respiratory physician affiliated with Massachusetts General Hospital. OpenAlex indexes 23 publications with 268 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
23publications

Distinct works indexed by OpenAlex, matched via ORCID.

268citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

55 Fruit St Bulfinch # 148
Boston, MA 021142621

Telephone

617-726-1721

Registry record last updated 11 Mar 2019.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    28.6%
    Endothelin Receptor Antagonist13.7%
    Opsumit93%Ambrisentan8%
    Part D<11 patients
    Loop diuretic7.1%
    Furosemide49%Torsemide28%Bumetanide24%
    Part D<11 patients

    + 3 more classes in this area

  • Genitourinary & hormones

    23.4%
    Phosphodiesterase 5 Inhibitor23.4%
    Sildenafil Citrate76%Tadalafil18%Adcirca6%
    Part D<11 patients
  • Blood & clotting

    21.5%
    Prostacycline Vasodilator12%
    Tyvaso Dpi63%Orenitram Er38%
    Part D<11 patients
    Prostacyclin Receptor Agonist6.8%
    Uptravi100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)94% facility · 6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”